YpsoMate 5.5 ml Successfully Integrated into RoboMat Labeling Platform

RoboMat successfully integrates the YpsoMate 5.5 ml into its flexible autoinjector labeling platform, supporting multiple device formats.

RoboMat has successfully integrated the new YpsoMate 5.5 ml autoinjector into its proven labeling platform, further expanding its capabilities for flexible pharmaceutical production.

A delegation of specialists from Ypsomed AG recently visited RoboMat to review the labeling process for the new 5.5 ml device format. The team positively assessed the handling and labeling concept, confirming the suitability of the solution for this new generation of autoinjectors.

One Platform. Multiple Autoinjector Formats.

The YpsoMate 5.5 ml is designed for higher-volume subcutaneous drug delivery and represents an important development in the growing autoinjector market.

Its successful integration demonstrates the flexibility of RoboMat’s platform approach. Different YpsoMate formats can be processed using the same proven machine concept, reducing the need for dedicated equipment for each device format.

Depending on production requirements, the labeling platform can be configured for:

  • Different production volumes and throughput requirements
  • Wrap-around and booklet labeling applications
  • Integrated vision inspection and quality control
  • Flexible product infeed and tray handling concepts

Flexible Automation for Changing Production Requirements

As pharmaceutical manufacturers face increasing product diversity and changing batch sizes, flexibility becomes a key requirement for production equipment.

RoboMat combines proven machine platforms with application-specific configurations to support both current and future autoinjector projects.

One platform. Multiple device formats. Built for future autoinjector projects.

We thank the Ypsomed team for their visit and constructive collaboration.

Find out more about our labling solutions.